Availability
0
Your Basket is Empty
D-0675

Deferoxamine mesylate

Deferoxamine is a very well known drug for the treatment of iron excess occurring in patients with thalassemia who are receiving regular transfusions. Excessive iron intake from diet may also cause accumulation of the metal ions which result in several symptoms such as metabolic acidosis and hypovolemic shock. The mechanism of action of Deferoxamine is based on its ability to chelate iron and other metal ions (i.e. aluminum) permitting their rapid urinary elimination. Recently, another potential therapeutic uses of Deferoxamine for treating diabetic neuropathy was suggested since it was observed that the drug could activate the production of pro-angiogenic, neuroprotective and anti inflammatory factors. Read the full story here: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0178011

Technical Data

CAS No: 138-14-7
Synonyms: Deforoxamine B mesylate; DFOM; DFX mesylate
Product Code: D-0675
MDL No: MFCD00058605
Chemical Formula: C26H52N6O11S
Molecular Weight: 656.79

References


Solubility

Stability

Further Information


Datasheets

Specification: View
MSDS: View

CAS No:
138-14-7
Synonyms:
Deforoxamine B mesylate
DFOM; DFX mesylate
MDL No:
MFCD00058605
Chemical Formula:
Molecular Weight:
656.79
Product Structure
Click for Specification
Click for MSDS

For requirements greater than the catalogue prepacks email: enquiries@carbosynth.com

Custom Synthesis

For custom synthesis or special requests email: enquiries@carbosynth.com, call +44 (0)1635 578444 or fill out our contact form

Please Wait...